The value of FDG PET/CT in the thromboembolic disease: review of the literature

Tritschler T., Kraaijpoel N., Le Gal G. et al. Venous Thromboembolism: Advances in Diagnosis and Treatment. JAMA 2018;15:1583–1594

Hess S., Frary E. C., Gerke O. et al. FDG-PET/CT in venous thromboembolism. Clinical and Translational Imaging 2018;5:369–378

Line B. R. Pathophysiology and diagnosis of deep venous thrombosis. Semin Nucl Med 2001;2:90–101

Rondina M. T., Lam U. T., Pendleton R. C. et al. (18)F-FDG PET in the evaluation of acuity of deep vein thrombosis. Clin Nucl Med 2012;12:1139–1145

Hara T., Truelove J., Tawakol A. et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography enables the detection of recurrent same-site deep vein thrombosis by illuminating recently formed, neutrophil-rich thrombus. Circulation 2014;13:1044–1052

Le Roux P. Y., Robin P., Delluc A. et al. Performance of 18F fluoro-2-desoxy-D-glucose positron emission tomography/computed tomography for the diagnosis of venous thromboembolism. Thromb Res 2015;1:31–35

Miceli M., Atoui R., Walker R. et al. Diagnosis of deep septic thrombophlebitis in cancer patients by fluorine-18 fluorodeoxyglucose positron emission tomography scanning: a preliminary report. J Clin Oncol 2004;10:1949–1956

Flavell R. R., Behr S. C., Brunsing R. L. et al. The incidence of pulmonary embolism and associated FDG-PET findings in IV contrast-enhanced PET/CT. Acad Radiol 2014;6:718–725

Rondina M. T., Wanner N., Pendleton R. C. et al. A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism. Thromb Res 2012;1:22–27

Alfonso A., Redondo M., Rubio T. et al. Screening for occult malignancy with FDG-PET/CT in patients with unprovoked venous thromboembolism. Int J Cancer 2013;9:2157–2164

Klein A., Shepshelovich D., Spectre G. et al. Screening for occult cancer in idiopathic venous thromboembolism - Systemic review and meta-analysis. Eur J Intern Med 2017:74–80

Galie N., Humbert M., Vachiery J. L. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016;1:67–119

Ahmadi A., Ohira H., Mielniczuk L. M. FDG PET imaging for identifying pulmonary hypertension and right heart failure. Curr Cardiol Rep [online]. 2015;1[cit. 22.4.2020]. DOI: 10.1007/s11886-014-0555-7.

Hagan G., Southwood M., Treacy C. et al. (18)FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: A proof-of-principle study. Pulm Circ 2011;4:448–455

Wang L., Li W., Yang Y. et al. Quantitative assessment of right ventricular glucose metabolism in idiopathic pulmonary arterial hypertension patients: a longitudinal study. Eur Heart J Cardiovasc Imaging 2016;10:1161–1168

Li W., Wang L., Xiong C. M. et al. The Prognostic Value of 18F-FDG Uptake Ratio Between the Right and Left Ventricles in Idiopathic Pulmonary Arterial Hypertension. Clin Nucl Med 2015;11:859–863

Kluge R., Barthel H., Pankau H. et al. Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension. J Nucl Med 2005;1:25–31

Sakao S., Daimon M., Voelkel N. F. et al. Right ventricular sugars and fats in chronic thromboembolic pulmonary hypertension. Int J Cardiol 2016:143–149

Jansa P., Aschermann M., Chronická plicní hypertenze. Praha, Maxdorf, 2017, 380 p